These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 16534789

  • 1. Survivin: an inhibitor of apoptosis in pediatric cancer.
    Fangusaro JR, Caldas H, Jiang Y, Altura RA.
    Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
    [Abstract] [Full Text] [Related]

  • 2. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
    Caldas H, Honsey LE, Altura RA.
    Mol Cancer; 2005 Mar 02; 4(1):11. PubMed ID: 15743529
    [Abstract] [Full Text] [Related]

  • 3. Survivin: a bifunctional inhibitor of apoptosis protein.
    Johnson ME, Howerth EW.
    Vet Pathol; 2004 Nov 02; 41(6):599-607. PubMed ID: 15557069
    [Abstract] [Full Text] [Related]

  • 4. Inhibitors of apoptosis proteins in human cervical cancer.
    Espinosa M, Cantú D, Herrera N, Lopez CM, De la Garza JG, Maldonado V, Melendez-Zajgla J.
    BMC Cancer; 2006 Feb 27; 6():45. PubMed ID: 16504151
    [Abstract] [Full Text] [Related]

  • 5. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.
    Chiou SK, Jones MK, Tarnawski AS.
    Med Sci Monit; 2003 Apr 27; 9(4):PI25-9. PubMed ID: 12709681
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H, Lu C, Mabuchi H, Tanigawa N.
    Cancer Lett; 2004 Dec 28; 216(2):147-55. PubMed ID: 15533590
    [Abstract] [Full Text] [Related]

  • 7. Survivin: a promising tumor biomarker.
    Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM.
    Cancer Lett; 2007 Apr 28; 249(1):49-60. PubMed ID: 17275177
    [Abstract] [Full Text] [Related]

  • 8. The universal character of the tumor-associated antigen survivin.
    Andersen MH, Svane IM, Becker JC, Straten PT.
    Clin Cancer Res; 2007 Oct 15; 13(20):5991-4. PubMed ID: 17947459
    [Abstract] [Full Text] [Related]

  • 9. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
    Capalbo G, Rödel C, Stauber RH, Knauer SK, Bache M, Kappler M, Rödel F.
    Strahlenther Onkol; 2007 Nov 15; 183(11):593-9. PubMed ID: 17960333
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y, Mowla SJ, Ziaee SA.
    Cancer Detect Prev; 2009 Nov 15; 32(4):308-13. PubMed ID: 19186007
    [Abstract] [Full Text] [Related]

  • 11. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
    Tröger A, Siepermann M, Mahotka C, Wethkamp N, Bülle H, Laws HJ, Escherich G, Janka-Schaub G, Göbel U, Dilloo D.
    Klin Padiatr; 2007 Nov 15; 219(3):127-33. PubMed ID: 17525905
    [Abstract] [Full Text] [Related]

  • 12. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R.
    J Pathol; 2007 Mar 15; 211(4):439-46. PubMed ID: 17253597
    [Abstract] [Full Text] [Related]

  • 13. Roles of survivin isoforms in the chemopreventive actions of NSAIDS on colon cancer cells.
    Mandayam S, Huang R, Tarnawski AS, Chiou SK.
    Apoptosis; 2007 Jun 15; 12(6):1109-16. PubMed ID: 17151952
    [Abstract] [Full Text] [Related]

  • 14. Survivin expression and its clinical significance in pancreatic cancer.
    Lee MA, Park GS, Lee HJ, Jung JH, Kang JH, Hong YS, Lee KS, Kim DG, Kim SN.
    BMC Cancer; 2005 Oct 04; 5():127. PubMed ID: 16202147
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 16. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 15; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 17. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
    Kleinberg L, Flørenes VA, Nesland JM, Davidson B.
    Am J Clin Pathol; 2007 Sep 15; 128(3):389-97. PubMed ID: 17709312
    [Abstract] [Full Text] [Related]

  • 18. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F.
    Cancer; 2008 May 15; 112(10):2258-66. PubMed ID: 18327814
    [Abstract] [Full Text] [Related]

  • 19. Survivin products in pituitary tumors.
    Jankowska A, Wasko R, Waligorska-Stachura J, Andrusiewicz M, Jaskula M, Liebert W, Sowinski J.
    Neuro Endocrinol Lett; 2008 Dec 15; 29(6):1033-7. PubMed ID: 19112393
    [Abstract] [Full Text] [Related]

  • 20. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T, Overman LM, Dignum H, Wood K, Crosier S, Angus B, Proctor SJ, Anderson JJ.
    Int J Oncol; 2008 Jan 15; 32(1):59-68. PubMed ID: 18097543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.